ShareLens™
A pragmatic way to estimate market share and model competitive evolution when research is limited.
What is ShareLens?
ShareLens is a lightweight analytics tool that triangulates equilibrium market shares and simulates sequential market dynamics. It combines three complementary models – Target Product Profile, Order of Entry, and Share of Voice – to give commercial teams a fast, defensible basis for share assumptions when primary research isn’t feasible or analogues aren’t reliable.
Ideal when:
- You’re forecasting niche or less-known markets
- Timelines or budgets preclude primary market research
- You need a cross-check alongside analogs and expert input
Why it matters
- Multi-factor view: No single model captures complex pharma market dynamics. ShareLens blends multiple lenses to create a more complete picture.
- Rapid triangulation: Move from assumptions to structured, parameterised estimates in hours, not weeks.
- Scenario-ready: Adjust key parameters (e.g., unmet need or promo sensitivity) to see how shares could shift.
- Portfolio alignment: Use consistent logic across brands and TAs to align planning assumptions.
Beyond equilibrium: Sequential market analysis
Most share tools stop at a single endpoint. ShareLens goes further, modelling market evolution over time as new entrants launch. This sequential view supports:
- Launch sequencing and readiness planning
- Competitive entry risk assessment
- Scenario comparisons (e.g., earlier vs later entry, promo ramp strategies)
What you get
- Interactive model build tailored to your TA and competitive set
- Parameterised scenarios (TPP weights/scores, unmet need, promo sensitivity, entry order)
- Equilibrium share outputs and sequential market evolution charts
- Short-form narrative: assumptions, rationale and implications for planning
- Optional training/workshop to embed the approach
Contact us at info@rlsconsultants.com to request your ShareLens custom market analysis or to discuss a tailored solution that fits your exact research needs.
